Gladius Capital Management LP acquired a new position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund acquired 10,409 shares of the company’s stock, valued at approximately $77,000.
Other hedge funds have also made changes to their positions in the company. Pacer Advisors Inc. acquired a new stake in Nu Skin Enterprises during the 2nd quarter worth $25,230,000. Federated Hermes Inc. boosted its position in Nu Skin Enterprises by 111.8% during the second quarter. Federated Hermes Inc. now owns 1,323,542 shares of the company’s stock worth $13,950,000 after acquiring an additional 698,722 shares during the last quarter. Vanguard Group Inc. grew its stake in Nu Skin Enterprises by 4.4% during the 1st quarter. Vanguard Group Inc. now owns 6,489,580 shares of the company’s stock valued at $89,751,000 after acquiring an additional 274,309 shares in the last quarter. Millennium Management LLC raised its holdings in Nu Skin Enterprises by 100.5% in the 2nd quarter. Millennium Management LLC now owns 534,579 shares of the company’s stock valued at $5,634,000 after acquiring an additional 267,965 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. lifted its stake in Nu Skin Enterprises by 178.3% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 283,355 shares of the company’s stock worth $3,919,000 after purchasing an additional 181,528 shares in the last quarter. Institutional investors and hedge funds own 82.84% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the company. Citigroup dropped their price target on Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating for the company in a research report on Tuesday, October 22nd. StockNews.com raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Monday, November 11th. Finally, DA Davidson reduced their price target on Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating on the stock in a report on Monday, August 12th.
Nu Skin Enterprises Stock Performance
Shares of NYSE NUS opened at $7.58 on Friday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.20 and a current ratio of 1.93. The company has a 50 day simple moving average of $6.74 and a 200-day simple moving average of $9.71. Nu Skin Enterprises, Inc. has a 1 year low of $5.95 and a 1 year high of $20.75.
Nu Skin Enterprises Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 11th. Shareholders of record on Friday, November 29th will be paid a dividend of $0.06 per share. The ex-dividend date of this dividend is Friday, November 29th. This represents a $0.24 annualized dividend and a yield of 3.17%. Nu Skin Enterprises’s dividend payout ratio (DPR) is -11.59%.
Nu Skin Enterprises Profile
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Recommended Stories
- Five stocks we like better than Nu Skin Enterprises
- What is Put Option Volume?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- How to Effectively Use the MarketBeat Ratings Screener
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- There Are Different Types of Stock To Invest In
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.